Bastide Le Confort Medical SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000035370
EUR
22.90
-28.6 (-55.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
Net Sales
491.18
461.87
508.03
468.30
444.07
382.71
335.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
491.18
461.87
508.03
468.30
444.07
382.71
335.73
Raw Material Cost
443.04
420.61
462.78
424.97
403.56
348.98
306.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
144.97
138.03
149.13
132.45
119.17
106.25
95.71
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
31.87
30.01
16.59
12.78
9.22
10.49
8.51
Selling and Distribution Expenses
1.87
2.06
1.16
1.90
0.84
0.39
1.34
Other Expenses
-17.68
-16.80
-16.57
-14.52
-12.84
-11.67
-10.42
Total Expenditure (Excl Depreciation)
444.91
422.66
463.93
426.86
404.41
349.37
308.01
Operating Profit (PBDIT) excl Other Income
46.3
39.2
44.1
41.4
39.7
33.3
27.7
Other Income
1.80
6.01
-0.33
-1.57
-1.91
-1.10
-0.93
Operating Profit (PBDIT)
105.05
100.29
100.40
93.37
85.86
79.35
63.65
Interest
31.87
30.01
16.59
12.78
9.22
10.49
8.51
Exceptional Items
-3.63
-2.15
-2.29
-3.53
-5.68
-0.88
-7.62
Gross Profit (PBDT)
48.14
41.27
45.26
43.33
40.51
33.73
29.06
Depreciation
59.03
55.01
58.80
56.05
50.80
47.70
36.16
Profit Before Tax
10.51
13.11
22.73
21.01
20.17
20.28
11.36
Tax
6.49
6.61
5.96
5.93
5.82
7.67
4.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3.02
4.40
16.07
14.44
13.45
11.60
5.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3.02
4.40
16.07
14.44
13.45
11.60
5.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.03
2.11
0.74
0.65
0.90
1.01
0.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4.05
6.50
16.80
15.09
14.35
12.61
6.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.45
0.45
0.45
0.45
0.45
0.45
0.45
Reserves
72.13
79.77
87.65
84.56
81.31
75.67
63.45
Earnings per share (EPS)
0.07
-0.12
1.53
1.87
1.84
1.58
0.62
Diluted Earnings per share
0.07
-0.12
1.53
1.87
1.84
1.58
0.62
Operating Profit Margin (Excl OI)
9.0%
8.5%
8.26%
8.3%
8.33%
8.56%
8.46%
Gross Profit Margin
14.16%
14.75%
16.05%
16.45%
15.98%
17.76%
14.15%
PAT Margin
0.61%
0.95%
3.16%
3.08%
3.03%
3.03%
1.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2025 is 6.34% vs -9.07% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Jun 2025 is -38.46% vs -61.31% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2025 is 9.54% vs -6.36% in Jun 2024

stock-summary

Interest

YoY Growth in year ended Jun 2025 is 6.33% vs 80.72% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jun 2025 has improved from Jun 2024

Compare Annual Results Of Bastide Le Confort Medical SA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
491.18
5,310.30
-4,819.12
-90.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
491.18
5,310.30
-4,819.12
-90.75%
Raw Material Cost
443.04
4,682.77
-4,239.73
-90.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
144.97
3,236.69
-3,091.72
-95.52%
Power Cost
0
0
0.00
Manufacturing Expenses
31.87
311.03
-279.16
-89.75%
Selling and Distribution Expenses
1.87
222.00
-220.13
-99.16%
Other Expenses
-17.68
-354.77
337.09
95.02%
Total Expenditure (Excl Depreciation)
444.91
4,904.77
-4,459.86
-90.93%
Operating Profit (PBDIT) excl Other Income
46.27
405.53
-359.26
-88.59%
Other Income
1.80
175.41
-173.61
-98.97%
Operating Profit (PBDIT)
105.05
1,187.58
-1,082.53
-91.15%
Interest
31.87
311.03
-279.16
-89.75%
Exceptional Items
-3.63
-149.48
145.85
97.57%
Gross Profit (PBDT)
48.14
627.53
-579.39
-92.33%
Depreciation
59.03
715.18
-656.15
-91.75%
Profit Before Tax
10.51
11.89
-1.38
-11.61%
Tax
6.49
-3.32
9.81
295.48%
Provisions and contingencies
0
0
0.00
Profit After Tax
3.02
1.59
1.43
89.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3.02
1.59
1.43
89.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.03
7.60
-6.57
-86.45%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4.05
9.20
-5.15
-55.98%
Equity Capital
0
0
0.00
Face Value
0.45
0.01
0.00
Reserves
72.13
3,613.66
-3,541.53
-98.00%
Earnings per share (EPS)
0.07
0.00
0.07
Diluted Earnings per share
0.07
0.00
0.07
Operating Profit Margin (Excl OI)
9.00%
5.59%
0.00
3.41%
Gross Profit Margin
14.16%
13.69%
0.00
0.47%
PAT Margin
0.61%
0.03%
0.00
0.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 49.12 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 6.34% vs -9.07% in Jun 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 0.40 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is -38.46% vs -61.31% in Jun 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.33 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 9.54% vs -6.36% in Jun 2024

Annual - Interest
Interest 3.19 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 6.33% vs 80.72% in Jun 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.00%
in Jun 2025

Figures in %
stock-summary

YoY Growth in year ended Jun 2025 has improved from Jun 2024